These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 23031240)

  • 1. [Probiotics have a limited role in the treatment of inflammatory bowel disease].
    Dieleman L; Hoentjen F
    Ned Tijdschr Geneeskd; 2012; 156(40):A5206. PubMed ID: 23031240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for probiotic treatment strategies in inflammatory bowel disease.
    Schultz M; Lindström AL
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and inflammatory bowel disease.
    Hammer HF
    Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics for inflammatory bowel disease: a critical appraisal.
    Sans M
    Dig Dis; 2009; 27 Suppl 1():111-4. PubMed ID: 20203506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    Marteau P; Sokol H; Dray X; Seksik P
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S228-34. PubMed ID: 20117346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of probiotics in inflammatory bowel disease.
    Cain AM; Karpa KD
    Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Probiotics in chronic inflammatory bowel disease].
    Böhm S; Kruis W
    MMW Fortschr Med; 2006 Aug; 148(35-36):30-4. PubMed ID: 16995360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children.
    Guandalini S; Cernat E; Moscoso D
    Benef Microbes; 2015; 6(2):209-17. PubMed ID: 25391345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Probiotics--should we change the treatment strategy for pouchitis?].
    Klinge LG; Kjeldsen J
    Ugeskr Laeger; 2006 Oct; 168(41):3516-8. PubMed ID: 17059804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of probiotic therapy in IBD.
    Isaacs K; Herfarth H
    Inflamm Bowel Dis; 2008 Nov; 14(11):1597-605. PubMed ID: 18421762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases.
    Chapman TM; Plosker GL; Figgitt DP
    BioDrugs; 2007; 21(1):61-3. PubMed ID: 17263590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?
    Cary VA; Boullata J
    J Clin Nurs; 2010 Apr; 19(7-8):904-16. PubMed ID: 20492035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
    Meijer BJ; Dieleman LA
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.